Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M W Jann

Showing results (1-10 of 91) with videos related to

Pageof 10
Sort By:
Pharmacotherapy|April 16, 1998
Preclinical pharmacology of metrifonateM W Jann
Pharmacotherapy|January 21, 2000
Rivastigmine, a new-generation cholinesterase inhibitor for the treatment of Alzheimer's diseaseM W Jann
The Journal of Clinical Psychiatry|September 1, 1994
Nonphysician prescribersM W Jann
Pharmacotherapy|January 1, 1988
Buspirone: an update on a unique anxiolytic agentM W Jann
Pharmacotherapy|January 1, 1991
ClozapineM W Jann
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 11, 1998
Pharmacology and clinical efficacy of cholinesterase inhibitorsM W Jann
Pharmacotherapy|September 1, 1993
The one who dies with the most letters behind his name winsM W Jann
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)|October 13, 2000
Supportive care for the patient with Alzheimer's diseaseM W Jann, N Brandt
Drug Metabolism and Drug Interactions|May 23, 2000
The influence of ethnicity and antidepressant pharmacogenetics in the treatment of depressionM W Jann, L J Cohen
Clinical Pharmacy|October 1, 1986
Effect of influenza vaccine on serum anticonvulsant concentrationsM W Jann, G S Fidone
Pageof 10

Showing results (1-10 of 91) with videos related to

Sort By:
Pageof 10
Pharmacotherapy|April 16, 1998
Preclinical pharmacology of metrifonateM W Jann
Pharmacotherapy|January 21, 2000
Rivastigmine, a new-generation cholinesterase inhibitor for the treatment of Alzheimer's diseaseM W Jann
The Journal of Clinical Psychiatry|September 1, 1994
Nonphysician prescribersM W Jann
Pharmacotherapy|January 1, 1988
Buspirone: an update on a unique anxiolytic agentM W Jann
Pharmacotherapy|January 1, 1991
ClozapineM W Jann
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 11, 1998
Pharmacology and clinical efficacy of cholinesterase inhibitorsM W Jann
Pharmacotherapy|September 1, 1993
The one who dies with the most letters behind his name winsM W Jann
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)|October 13, 2000
Supportive care for the patient with Alzheimer's diseaseM W Jann, N Brandt
Drug Metabolism and Drug Interactions|May 23, 2000
The influence of ethnicity and antidepressant pharmacogenetics in the treatment of depressionM W Jann, L J Cohen
Clinical Pharmacy|October 1, 1986
Effect of influenza vaccine on serum anticonvulsant concentrationsM W Jann, G S Fidone
Pageof 10